Personal information

No personal information available

Activities

Works (6)

Clinical Translation of a Dual-Integrin αvβ3- and CD13-Targeting PET Tracer

Clinical Nuclear Medicine
2025-04 | Journal article
Contributors: Xiao Zhang; Biao Yang; Chunxia Qin; Xiangming Song; Xiaoying Lv; Dexing Zeng; Yongkang Gai; Xiaoli Lan
Source: check_circle
Crossref

Development of Dual Receptor Enhanced Pre‐Targeting Strategy—A Novel Promising Technology for Immuno‐Positron Emission Tomography Imaging

Advanced Therapeutics
2021-10 | Journal article
Contributors: Lingyi Sun; Yongkang Gai; Zhonghan Li; Xiaohui Zhang; Jianchun Li; Yongyong Ma; Huiqiang Li; Ramon F. Barajas, Jr.; Dexing Zeng
Source: check_circle
Crossref

PET Imaging of CD8 via SMART for Monitoring the Immunotherapy Response

BioMed Research International
2021-01 | Journal article
Contributors: Lingyi Sun; Zhonghan Li; Yongyong Ma; Johannes Ludwig; Hyun S. Kim; Dexing Zeng; Kazuma Ogawa
Source: check_circle
Crossref

Photo-Click-Facilitated Screening Platform for the Development of Hetero-Bivalent Agents with High Potency

The Journal of Organic Chemistry
2020-05-01 | Journal article
Contributors: Lingyi Sun; Yongkang Gai; Christopher D. McNitt; Jun Sun; Xiaohui Zhang; Wei Xing; Zhonghan Li; Vladimir V. Popik; Dexing Zeng
Source: check_circle
Crossref

Evaluation of an Integrin αvβ3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging

Molecular Pharmaceutics
2020-01-06 | Journal article
Contributors: Yongkang Gai; Yaqun Jiang; Yu Long; Lingyi Sun; Qingyao Liu; Chunxia Qin; Yongxue Zhang; Dexing Zeng; Xiaoli Lan
Source: check_circle
Crossref

64Cu-Labeled Ubiquitin for PET Imaging of CXCR4 Expression in Mouse Breast Tumor

ACS Omega
2019-07-31 | Journal article
Contributors: Huiqiang Li; Xiaohui Zhang; Hsuan Yi Wu; Lingyi Sun; Yongyong Ma; Junling Xu; Qing Lin; Dexing Zeng
Source: check_circle
Crossref

Peer review (19 reviews for 4 publications/grants)

Review activity for ACS applied materials & interfaces. (5)
Review activity for ACS nano. (1)
Review activity for Bioconjugate chemistry. (6)
Review activity for Molecular pharmaceutics. (7)